Skip to search formSkip to main contentSkip to account menu

iotrex

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Benzenesulfonates

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
The role of dose escalation with intracavitary brachytherapy in the treatment of localized CNS malignancies: outcomes and toxicities of a prospective study.
Review
2006
Review
2006
GliaSite brachytherapy for treatment of recurrent malignant gliomas: a retrospective multi-institutional analysis.
OBJECTIVE To review the cumulative experience of 10 institutions in treating recurrent malignant gliomas with the brachytherapy… 
2005
2005
Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy
1544 Background: Glioblastoma multiforme is a primary malignancy of the central nervous system that is fatal despite treatment… 
2002
2002
Preclinical evaluation of a novel device for delivering brachytherapy to the margins of resected brain tumor cavities.
OBJECT The objectives of this study were to evaluate the safety and performance of a new brachytherapy applicator in the… 
2001
2001
Experimental validation of dose calculation algorithms for the GliaSite RTS, a novel 125I liquid-filled balloon brachytherapy applicator.
This paper compares experimentally measured and calculated dose-rate distributions for a novel 125I liquid-filled brachytherapy… 
2000
2000
Biodistribution and dosimetry of an aqueous solution containing sodium 3-(125I)iodo-4-hydroxybenzenesulfonate (Iotrex) for brachytherapy of resected malignant brain tumors.
UNLABELLED Iotrex is an aqueous radiotherapy solution containing sodium 3-(125I)iodo-4-hydroxybenzenesulfonate (125I-HBS), which… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)